Information Provided By:
Fly News Breaks for April 24, 2019
SYK
Apr 24, 2019 | 05:09 EDT
Piper Jaffray analyst Matt O'Brien says Stryker reported a "clean" Q1 with beats on both the top- and bottom-lines. The Mako story continues with 35 global placements, O'Brien tells investors in a research note. Stryker's "broad-based momentum" continues, and it remains in the upper-quartile of large cap medtech growth, adds the analyst. He reiterates an Overweight rating on the stock with a $205 price target.